bluelayer安卓下载

bluelayer安卓下载

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

bluelayer安卓下载

Learn More
Folded page of a newspaper

bluelayer安卓下载

bluelayer安卓下载

Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results

bluelayer安卓下载

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

bluelayer安卓下载

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

bluelayer安卓下载

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

bluelayer安卓下载

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

bluelayer安卓下载

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

蚂蚁加速npv下载官网  佛跳墙2025破解免登录  非凡加速  黑洞加速器永久2025  蚂蚁npv加速器官网网址  老王加速下载器下载